Arkolith/Insider Trading/PLYX/Form 4

Landis G. Michael

Chief Financial Officer, DirectorPolaryx Therapeutics, Inc. (PLYX) · full profile →Form 4 · filed Feb 20, 2026
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Buy(P)3K$2.79$8K228K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-018845) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML